Close
Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024 Jun 1, 2024 02:20PM
  • Nearly 98% of patients experience quality of life impact as a result of tardive dyskinesia (TD) including social, psychological, physical and recreational aspects of daily living
  • Data highlight for the first time that TD has a multidimensional impact on patients including those with mild TD severity
  • IMPACT-TD Registry is the largest-ever study of its kind evaluating the holistic effects of TD over three years along with real-world treatment patterns and outcomes... (continue reading...)

Karyopharm Presents Updated Exploratory Subgroup Analyses from SIENDO Study in Patients with Advanced or Recurrent TP53 Wild-Type Endometrial Cancer During 2024 ASCO Plenary Series: Rapid Abstract Upd Jun 1, 2024 01:45PM

Long-Term Follow-Up Data Signal Promising Progression-Free Survival (PFS) for Selinexor in the Maintenance Setting with Median PFS of 28.4 Months in the TP53 Wild-Type and 39.5 Months in the Proficient Mismatched Repair Status (pMMR) TP53 Wild-Type Exploratory Subgroups

Q-TWiST, an Important Metric Assessing Both Quality and Quantity of Clinical Benefit, Suggests Improvement with Selinexor versus Placebo, which is Critical in the Maintenance Setting

Company... (continue reading...)


Thrive with GBA | The Bay to Bay Dialogue held to deepen mutual understanding between China and US Jun 1, 2024 01:42PM

GUANGZHOU, China, May 31, 2024 /PRNewswire/ -- A news report from GDToday: 

Organized by the Guangdong Government, the Government of the State of California, Chinese People's for Friendship with Foreign Countries and California China Climate Institute, the first US-China Bay to Bay Dialogue was held in Berkeley, California on May 29 (local time).

More than 200 representatives from both sides attended the Dialogue, including Guangdong... (continue reading...)


All-in-One Job Shop Software for Fabrication Shops by Steelhead Technologies Jun 1, 2024 01:20PM

Steelhead Technologies, a leading innovator in job shop software, announces a groundbreaking enhancement to its comprehensive platform with the introduction of advanced Fabrication Management features. This update empowers manufacturers to tackle larger projects with ease, alleviate stress, and eliminate the hassle of searching for parts during production. 

Gone are the days of inefficient shop floor operations and interruptions in... (continue reading...)


Sustainable Tourism Initiative: Responsible Travel Merchandise Store Announced Jun 1, 2024 12:43PM

As many popular travel destinations suffer from the destructive impacts of overtourism, Ever Wonder Adventure announces a new sustainable travel guide and merchandise store to promote sustainable tourism practices.

With locations such as Boracay, Venice, and Maya Bay demonstrating the risks of over tourism, a new online guide known as Ever Wonder Adventure has been launched detailing some of the world’s top sustainable travel... (continue reading...)


More Press Releases

View Older Stories

Jun 1, 2024 02:20PM What Custom Stickers Are Best for Glass?
Jun 1, 2024 02:20PM Robotbulls - The Future of Cryptocurrency Trading: Integrating AI and Blockchain Data
Jun 1, 2024 01:10PM Taseko Announces that Operations at its Gibraltar Mine have been Suspended
Jun 1, 2024 12:59PM Michael Bernstein Offers Dropshipping Consulting to Help Clients Build Successful, Long-Term Businesses
Jun 1, 2024 01:02PM Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort
Jun 1, 2024 01:01PM PHILADELPHIA KICKS OFF PRIDE MONTH BY SETTING THE FIRST-EVER GUINNESS WORLD RECORDS™ FOR THE "LARGEST ATTENDANCE AT DRAG QUEEN STORY TIME"
Jun 1, 2024 12:55PM Union members and allies mark Injured Workers’ Day in locations across Ontario
Jun 1, 2024 12:30PM FameEX CEO’s Message: Keep the Intention in the Crypto Bull Market for a Better Departure
Jun 1, 2024 12:36PM Prospera Energy Inc. Announces 2023 Financial Results
Jun 1, 2024 11:40AM Z Grills Announces Unprecedented "Buy 1, Get 10 Grills" Promotion, Unlocking a Lifetime of Easier Grilling!
Jun 1, 2024 11:00AM WATCH by Aisles: A Revolutionary AI System for Public Safety
Jun 1, 2024 11:56AM CIO Women Magazine Spotlights Claudia Patricia Eusse, CEO, The Eusse Group, as Influential Women Leaders in Real Estate
Jun 1, 2024 11:56AM Mr. Business Magazine Spotlights Diana Muniz-Lebrun, Founding Partner and CEO at Olympus Marketing
Jun 1, 2024 11:00AM ICECO Launches APL35 on Indiegogo - The World's Lightest Aluminum Dual-Zone Freezer
Jun 1, 2024 10:00AM SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical
Jun 1, 2024 10:00AM Tag along with Jason in Zhengzhou: Experiencing Kung Fu at the Shaolin Temple
Jun 1, 2024 10:00AM First Ascent Biomedical Presents Findings from Clinical Studies in Pediatric and Adult Cancers Using its AI-Enhanced Functional Precision Medicine Platform at ASCO 2024
Jun 1, 2024 10:00AM "Experience the Luxury of Japanese Tradition and Cuisine" Reservations for the New Inbound Experience Tour in Osaka's Tondabayashi Begin on June 1, 2024!
Jun 1, 2024 10:00AM Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 1, 2024 10:00AM Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-sma
Jun 1, 2024 10:33AM Gregory P Lee Personal Injury Lawyer The Woodlands Expands Services to Meet Rising Demand in Texas for Personal Injury Cases
Jun 1, 2024 10:30AM Innovative Solutions and Cutting-Edge Technologies Take Centre Stage at Water Expo Delhi 2024
Jun 1, 2024 10:28AM Revolutionizing Sustainability: The Environment Protection Technologies Expo
Jun 1, 2024 09:30AM Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC
Jun 1, 2024 09:15AM Postmedia Announces Closing of Previously Announced Transaction with the Klein Group
Jun 1, 2024 09:14AM Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing
Jun 1, 2024 09:00AM Fungies Mushroom Gummies Announces Major Retail Expansion and Availability at Walmart
Jun 1, 2024 09:00AM Vincent Todd Announces the Introduction of Todd Agriscience
Jun 1, 2024 09:00AM Hyundai Motor America Reports May 2024 Sales
Jun 1, 2024 09:00AM Beverly Hills MD Celebrates Its 10th Anniversary
Jun 1, 2024 09:00AM American Cancer Society and American Society of Clinical Oncology Unite to Create One of the Largest and Most Comprehensive Online Sources of Credible Cancer Information
Jun 1, 2024 09:00AM Ankyra Therapeutics Announces Trial in Progress Poster Presentation at 2024 ASCO Meeting and Approval of ANK-101 Phase 1 Protocol Amendment
Jun 1, 2024 09:00AM Sally Hansen® and GLAAD Reprise Their Partnership for the 6th Year With a Launch That Celebrates the LGBTQ+ Community
Jun 1, 2024 09:00AM Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
Jun 1, 2024 09:00AM ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
Jun 1, 2024 09:18AM 5 Ways BPO Services Can Improve Your Business Operations
Jun 1, 2024 09:18AM Amazed by these incredible facts about the yellow diamond
Jun 1, 2024 09:18AM Maximizing Efficiency: The Role of Content Moderation Services
Jun 1, 2024 09:18AM Wisconsin Top Performing Stocks
Jun 1, 2024 08:15AM FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 1, 2024 08:15AM Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Jun 1, 2024 08:15AM Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
Jun 1, 2024 08:10AM Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual
Jun 1, 2024 08:05AM Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
Jun 1, 2024 08:05AM Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
Jun 1, 2024 08:00AM Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
Jun 1, 2024 08:00AM Immunocan Launches Innovative Alpaca-derived Nanobody Discovery Platform: ImmuAlpaca® Mouse
Jun 1, 2024 08:00AM James Avery Artisan Jewelry Opens New Store at Westover Marketplace
Jun 1, 2024 08:00AM Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
Jun 1, 2024 08:00AM TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024 Annual Meeting
View Older Stories